La Jolla Pharmaceutical Company (LJPC):企業の財務・戦略的SWOT分析

◆英語タイトル:La Jolla Pharmaceutical Company (LJPC) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH66490FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

La Jolla Pharmaceutical Company (LJPC) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

La Jolla Pharmaceutical Company (La Jolla) discovers, develops and commercializes biopharmaceutical products for life threatening diseases. The company’s major product includes the US FDA approved Giapreza, an injection for intravenous infusion indicated to increase blood pressure in adults with septic or other distributive shock. Its investigational product candidates include LJPC-0118 intended for the treatment of severe malaria and LJPC-401, a proprietary formulation of synthetic human hepcidin, an endogenous peptide hormone intended for the prevention of excessive iron accumulation in vital organs. The company sells Giapreza to hospitals in the US through a network of wholesale and specialty distributors. La Jolla is headquartered in San Diego, California, the US.

La Jolla Pharmaceutical Company Key Recent Developments

Dec 31,2020: La Jolla Pharmaceutical announces financial results for the three and twelve months ended December 31, 2020
Nov 09,2020: La Jolla Pharmaceutical Company announces financial results for the three and nine months ended September 30, 2020
Oct 29,2020: La Jolla Pharmaceutical Company announces appointment of Larry Edwards
Sep 30,2020: La Jolla Pharmaceutical announces change of certain officers
Aug 06,2020: La Jolla Pharmaceutical announces financial results for the three and six months ended June 30, 2020 and highlights recent corporate progress

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
La Jolla Pharmaceutical Company – Key Facts
La Jolla Pharmaceutical Company – Key Employees
La Jolla Pharmaceutical Company – Key Employee Biographies
La Jolla Pharmaceutical Company – Major Products and Services
La Jolla Pharmaceutical Company – History
La Jolla Pharmaceutical Company – Company Statement
La Jolla Pharmaceutical Company – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
La Jolla Pharmaceutical Company – Business Description
La Jolla Pharmaceutical Company – SWOT Analysis
SWOT Analysis – Overview
La Jolla Pharmaceutical Company – Strengths
La Jolla Pharmaceutical Company – Weaknesses
La Jolla Pharmaceutical Company – Opportunities
La Jolla Pharmaceutical Company – Threats
La Jolla Pharmaceutical Company – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
La Jolla Pharmaceutical Company, Recent Deals Summary
Section 5 – Company’s Recent Developments
Dec 31, 2020: La Jolla Pharmaceutical announces financial results for the three and twelve months ended December 31, 2020
Nov 09, 2020: La Jolla Pharmaceutical Company announces financial results for the three and nine months ended September 30, 2020
Oct 29, 2020: La Jolla Pharmaceutical Company announces appointment of Larry Edwards
Sep 30, 2020: La Jolla Pharmaceutical announces change of certain officers
Aug 06, 2020: La Jolla Pharmaceutical announces financial results for the three and six months ended June 30, 2020 and highlights recent corporate progress
Jul 28, 2020: Larry Edwards appointed president and chief executive officer of La Jolla Pharmaceutical Company
Jun 02, 2020: La Jolla Pharmaceutical Company announces board changes
May 04, 2020: La Jolla Pharmaceutical Company announces financial results for the three months ended March 31, 2020
Mar 02, 2020: La Jolla Pharmaceutical Company announces financial results for the three and twelve months ended December 31, 2019
Jan 09, 2020: La Jolla Pharmaceutical Company announces preliminary GIAPREZA (Angiotensin II) net sales for the three and twelve months ended December 31, 2019
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
La Jolla Pharmaceutical Company, Key Facts
La Jolla Pharmaceutical Company, Key Employees
La Jolla Pharmaceutical Company, Key Employee Biographies
La Jolla Pharmaceutical Company, Major Products and Services
La Jolla Pharmaceutical Company, History
La Jolla Pharmaceutical Company, Subsidiaries
La Jolla Pharmaceutical Company, Key Competitors
La Jolla Pharmaceutical Company, Ratios based on current share price
La Jolla Pharmaceutical Company, Annual Ratios
La Jolla Pharmaceutical Company, Annual Ratios (Cont...1)
La Jolla Pharmaceutical Company, Interim Ratios
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
La Jolla Pharmaceutical Company, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[La Jolla Pharmaceutical Company (LJPC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Alucon Public Company Limited:戦略・SWOT・企業財務分析
    Alucon Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Alucon Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Currence Holding B.V.:企業の戦略・SWOT・財務分析
    Currence Holding B.V. - Strategy, SWOT and Corporate Finance Report Summary Currence Holding B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Hospira Inc:医療機器:M&Aディール及び事業提携情報
    Summary Hospira Inc (Hospira), a subsidiary of Pfizer Inc, is a medical device company that offers injectable drugs and infusion technologies. The company offers products such as generic acute-care and oncology injectables, biosimilars, infusion systems, IV sets, IV safety devices, biosimilars, diff …
  • Hitachi Zosen Corporation (7004):企業の財務・戦略的SWOT分析
    Hitachi Zosen Corporation (7004) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Guararapes Confeccoes SA:企業の戦略・SWOT・財務情報
    Guararapes Confeccoes SA - Strategy, SWOT and Corporate Finance Report Summary Guararapes Confeccoes SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Elite Pharmaceuticals Inc (ELTP):製薬・医療:M&Aディール及び事業提携情報
    Summary Elite Pharmaceuticals Inc (Elite) is a specialty pharmaceutical company focuses on the development of oral sustained and controlled release drug products. The company manufactures and develops generic drugs with Abbreviated New Drug Applications (ANDA) and branded drugs with New Drug Applica …
  • Sui Northern Gas Pipelines Ltd (SNGP):企業の財務・戦略的SWOT分析
    Sui Northern Gas Pipelines Ltd (SNGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Oki Electric Industry Co., Ltd. (6703):企業の財務・戦略的SWOT分析
    Oki Electric Industry Co., Ltd. (6703) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • National Real Estate Company K.S.C.:企業の戦略・SWOT・財務情報
    National Real Estate Company K.S.C. - Strategy, SWOT and Corporate Finance Report Summary National Real Estate Company K.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Westar Energy Inc.:企業の戦略・SWOT・財務情報
    Westar Energy Inc. - Strategy, SWOT and Corporate Finance Report Summary Westar Energy Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Pasteur Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Pasteur Institute is a non-profit foundation that provides research, health services and teaching services. The foundation conducts research in the areas of biology, genomes and genetics, immunology, infection and epidemiology, microbiology, neuroscience, parasitology and mycology, structura …
  • SoCore Energy LLC:電力:M&Aディール及び事業提携情報
    Summary SoCore Energy LLC (SoCore Energy), a subsidiary of Edison International is a provider of solar solutions. The company’s services include solar energy development and installations, production monitoring, cost saving energy solutions, financing, procurement, technical and project management, …
  • DURECT Corp (DRRX):企業の財務・戦略的SWOT分析
    DURECT Corp (DRRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Tata Teleservices (Maharashtra) Ltd (TTML):企業の財務・戦略的SWOT分析
    Tata Teleservices (Maharashtra) Ltd (TTML) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Harbor MedTech Inc:医療機器:M&Aディール及び事業提携情報
    Summary Harbor MedTech Inc (Harbor MedTech) is a commercial-stage regenerative medicine company that offers tissue regeneration solutions. The company offers Architect, an extracellular collagen matrix used in managing partial and full thickness wounds. Its collagen wound matrix systems are used in …
  • DNO ASA (DNO):石油・ガス:M&Aディール及び事業提携情報
    Summary DNO ASA (DNO) is an oil and gas company that provides mineral properties exploration and development services. The company's services include selective and targeted drilling, fractured carbonate plays that are characteristic of the MENA region. It also provides operations in petroleum, shipp …
  • Applied Materials Inc (AMAT):企業の財務・戦略的SWOT分析
    Applied Materials Inc (AMAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • NOWDiagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary NOWDiagnostics Inc (NOWDiagnostics) is a medical diagnostic company. The company manufactures and sells blood-based rapid tests. It offers acetaminophen test, hCG test, H-FABP test, methanol dip test, salicylate test, troponin I test, myoglobin test, in home HIV test, and others. NOWDiagnost …
  • Cleco Corporate Holdings LLC:企業の戦略的SWOT分析
    Cleco Corporate Holdings LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Scb Life Assurance Public Company Limited
    Scb Life Assurance Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Scb Life Assurance Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆